Factors related to the host's susceptibility to infection are ____.
A. age and nutritional status
B. the number and concentration of pathogens
C. living conditions of the host
D. exposure to hazardous substances
E. the virulence of the pathogen
A. age and nutritional status
Factors related to the susceptibility of the host include age, genetic predisposition, nutritional status, other disease processes, stress levels, hygiene habits, and general health.
You might also like to view...
You respond to a report of a "person seizing." The patient is a 74-year-old female who is experiencing uncontrollable movements of the skeletal muscles in her extremities and face. She is awake, alert, and extremely agitated and restless. The patient has NO history of cerebrovascular accident, seizures, or other neurologic disease. You discover that the patient's physician recently placed her on
a new medication, but neither she nor her family can remember what the name of the drug is. Which of the following drugs would be MOST likely to produce these effects? a. Elavil c. Librium b. Thorazine d. Lithium carbonate
A patient with a low blood sugar is unresponsive with snoring respirations. His breathing is labored and his pulse is rapid and weak. Examination of the skin reveals it to be cool and diaphoretic. Your partner informs you of the following vital signs: pulse, 120; respirations, 18 breaths/min; blood pressure, 132/60 mmHg; and SpO2 at 84% on room air. Which action would you perform first?
A) Administer oral glucose B) Perform a head-tilt, chin-lift maneuver C) Provide high-concentration oxygen D) Start positive pressure ventilation
The clumping of red blood cells following a blood transfusion is ________.
Fill in the blank(s) with the appropriate word(s).
According to ASHP guidelines, Risk level 1 includes all of the following products EXCEPT those that are:
A) Stored at room temperature and completely administered within 28 hours of preparation. B) Unpreserved, sterile, and prepared for administration to more than one patient and contain suitable preservatives. C) Prepared by a closed-system aseptic transfer of sterile, nonpyrogenic, finished pharmaceuticals obtained from licensed manufacturers into sterile final containers obtained from licensed manufacturers. D) Prepared by combining multiple ingredients, sterile or non-sterile, by using an open-system transfer before terminal sterilization.